0000899243-18-012754.txt : 20180514
0000899243-18-012754.hdr.sgml : 20180514
20180514173559
ACCESSION NUMBER: 0000899243-18-012754
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180511
FILED AS OF DATE: 20180514
DATE AS OF CHANGE: 20180514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: North Michael Paul
CENTRAL INDEX KEY: 0001689925
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 18832113
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY, SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-11
0
0000896262
AMEDISYS INC
AMED
0001689925
North Michael Paul
3854 AMERICAN WAY, SUITE A
BATON ROUGE
LA
70816
0
1
0
0
Chief Information Officer
Common Stock
2018-05-11
4
M
0
11000
32.56
A
33848
D
Common Stock
2018-05-11
4
S
0
800
70.74
D
33048
D
Common Stock
2018-05-11
4
S
0
10200
71.58
D
22848
D
Common Stock
296
I
Through 401(k) Plan
Stock Option (Right to Buy)
32.56
2018-05-11
4
M
0
11000
0.00
D
2025-06-02
Common Stock
11000
11500
D
Includes 594 shares held in an employee stock purchase plan account.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.62 to $70.84, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.10 to $71.85, inclusive.
The information in this report is based on a plan statement dated as of March 31, 2018.
The Stock Options are subject to time-based vesting conditions. 5,625 Stock Options vested on June 2, 2016, 5,625 Stock Options vested on June 2, 2017, and the remaining 11,250 Stock Options will vest in installments of 5,625 Stock Options on each of June 2, 2018 and June 2, 2019, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
/s/ Jennifer R. Guckert, pursuant to a power of attorney
2018-05-14